Medway School of Pharmacy

Medway School of Pharmacy

Medical examination in a doctor's room

Medicines Optimisation - PCert, PDip, MSc

2026

Learn how Medicines Optimisation is used to determine how medicines are used by patients and the NHS. Effective medicines optimisation places the patient as the primary focus of interventions by healthcare professionals and is a key driver for NHS modernisation in the UK. Become proficient in planning clinical and cost-effective medicines use in the context of the holistic consideration of patient needs.One pathway to the MSc includes the chance for you to qualify as an independent/supplementary prescriber. Have a look at the Independent / Supplementary Prescribing programme for more details.

2026

Overview

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

Fees

For fee information, please email MSOPPGTAdmin@greenwich.ac.uk

National ratings

In the Research Excellence Framework (REF) 2021, over 85% of our Allied health professions, dentistry, nursing and pharmacy research* was classified as ‘world-leading’ or ‘internationally excellent’ for output and environment.

* Joint submission with University of Greenwich.

Project Titles Supervisors
Sleep, circadian rhythms and wellbeing - from molecular mechanisms to clinical applications Dr Gurprit Lall, Dr Aiste Steponenaite
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers Dr Andrew J Hall, Dr Nigel Temperton
Cross-talks of immune checkpoint pathways determine the abilities of human malignant tumours to suppress cytotoxic attacks and escape immune surveillance Dr Vadim V Sumbayev
Understanding the link between head injuries and Alzheimer's disease. Dr Romina Vuono
Using advanced machine learning strategies to map early osteoarthritis changes and predict disease progression in preclinical models Dr Sadaf Ashraf